BioVersys AG (SWX:BIOV)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
26.60
-0.80 (-2.92%)
At close: Jul 31, 2026

BioVersys AG Balance Sheet

Millions CHF. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Cash & Equivalents
82.5126.6224.38
Short-Term Investments
-64
Cash & Short-Term Investments
82.5132.6228.38
Cash Growth
152.94%14.95%-
Other Current Assets
7.371.785.21
Total Current Assets
89.8734.433.59
Net Property, Plant & Equipment
0.770.560.58
Total Assets
90.6434.9634.17

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Accounts Payable
2.470.711.29
Accrued Expenses
2.873.452.2
Current Portion of Leases
1.214.311.78
Other Current Liabilities
2.351.224.09
Total Current Liabilities
8.99.679.37
Long-Term Debt
21.4413.7615.68
Other Long-Term Liabilities
0.490.840.55
Total Long-Term Liabilities
21.9314.616.22
Total Liabilities
30.8324.2725.59

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Common Stock
5.853.693.06
Additional Paid-in Capital
155.687.468.77
Accumulated Other Comprehensive Income
-0.51-0.07-0.32
Retained Earnings
-101.13-80.34-62.94
Shareholders' Equity
59.8110.688.58
Total Liabilities & Equity
90.6434.9634.17

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
Total Debt
22.6518.0717.46
Net Cash (Debt)
59.8614.5510.91
Net Cash Growth
311.30%33.34%-
Net Cash Per Share
10.664.373.65
Book Value
59.8110.688.58
Book Value Per Share
10.653.212.87
Tangible Book Value
59.8110.688.58
Tangible Book Value Per Share
10.653.212.87